BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, December 22, 2025
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

July 19, 2010

View Archived Issues

Researchers cite ways to regulate conflicts of interest

Academic scientists seeking financial support of their work tend to find themselves in a bit of a pickle. They need funding, often provided by industry, to help spur innovation through their research, but that support tends to result in – either real or perceived – bias in favor of their industry partner. (Medical Device Daily) Read More

Stentys enrolls final patient in its APPOSITION II study

Read More

Report from Europe: ClariVein vein ablation system introduced in Europe

Read More

Washington roundup: FDA eyes public information campaigns for med-tech items

Read More

Deals roundup: ON Semiconductor to purchase Sanyo subsidiary for $366M

Read More

MDD's food for med-tech thought

Read More

Financings roundup: BioMimetic prices offering, seeks to raise $40 million

Read More

Court report: Zoll in suit against Philips over several patents

Read More

People in the News

Read More

People in the News

Read More

Agreements/contracts: Eurotech to supply computers to blood management OEM

Read More

Grants roundup: Johns Hopkins receives $34.5 million to develop MPL

Read More

Product Briefs

Read More

MDD's Diagnostic Extra

Read More

Challenges linger, but VCs see promise in device side

Venture capitalists in this industry have a lot weighing on their mind these days: an increasingly erratic regulatory process, new FDA leadership, healthcare reform, growing economic uncertainty in Europe, and the U.S. economy is just now beginning to rebound after a difficult 2008 and 2009. (Medical Device Daily) Read More

Financings roundup: RoundTable reports closing on $800M in equity funds

Read More

International report: Lantheus launches Definity imaging agent in India

Read More

Washington roundup: Senate mirrors administration on FDA budget for fiscal 2011

Read More

MDD's food for med-tech thought

Read More

Grants roundup: MJFF committed to spend $12M or Parkinson's research

Read More

Patent watch: Ingen enter diabetes drug market with new product

Read More

Agreements/contracts: Purdue, Techshot partner to access new technology

Read More

People in the News

Read More

Med-Tech Notes

Read More

Deals roundup: GHP, PCF purchase Sterimed for undisclosed amount

Read More

Product Briefs

Read More

MDD's Neurology Extra

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 19, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 19, 2025.
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing